c-Ablの自己阻害が認められる
Helma Pluk1, Karel Dorey, Giulio Superti-Furga
1Developmental Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Cell
|February 8, 2002
まとめ
研究者らは,c-Ablチロシンキナーゼがc-Ablチロシンキナーゼに作用することを発見しました.
科学分野:
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
- 腫瘍学 腫瘍学
背景:
- c-Ablチロシンキナーゼの活性を制御する正確な分子機構は,長年にわたる研究問題となっています.
- c-Ablの調節不全は,様々な癌,特に,BCR-Abl融合タンパク質による慢性骨髄性白血病に関与しています.
研究 の 目的:
- c-Ablチロシンキナーゼの内在的な調節メカニズムを解明する.
- c-Abl自己調節に責任を負う特定のタンパク質ドメインを特定する.
- 腫瘍形成におけるc-Abl調節とBCR-Ablの規制緩和の役割を理解する.
主な方法:
- 精製されたc-Ablタンパク質を用いたインビトロ触媒活性アッセイ.
- タンパク質とタンパク質の相互作用を調査するための生化学分析.
- c-Abl活動に対するN端末改変の機能的影響の評価.
主要な成果:
- c-Ablは内在的な抑制能力を持ち,自身の触媒活動を調節することを実証した.
- N-ターミナル80残基を,自己調節を媒介する重要な"キャップ"ドメインとして特定しました.
- このN末端のキャップドメインの喪失は腫瘍性変異を引き起こし,BCR-Ablの規制緩和に寄与することを示した.
結論:
- 自律調節は,c-Ablチロシンキナーゼの固有性であり,そのN端領域によって媒介されます.
- N端のキャップは,c-Abl抑制を維持するために不可欠です.
- この規制上限の破壊は,c-Ablの腫瘍性活性化とBCR-Ablに関連する白血病発生における重要な出来事です.
関連する概念動画
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...